Empowerment through Education, Part V: Navigating Medical Cannabis Regulations In Part V of this interview series, Jeremy Robbins and David Benedicktus, co-founders of Cannabis Patients Pacific Northwest (CPPNW), explain how physician perspective, the current scheduling of cannabis, and the differing state laws surrounding medical cannabis create challenges for accessing cannabis education and medicine. ➡️ Catch up on the latest installment: https://ow.ly/FSRk50Qypci
Cannabis Patient Care’s Post
More Relevant Posts
-
The good news: Rescheduling cannabis to Schedule III is an acknowledgement by the federal government that cannabis has an accepted medical use and may lawfully be dispensed by prescription. The bad news: Only 2% of doctors have dosing knowledge, which has historically left 98% of all patients using cannabis-as-a-medicine to self-medicate. Not ideal or safe. The exciting news: ExstoBio has been busy over the past 2 years building a solution to help doctors facilitate science-based, data-driven medical cannabis care from start-to-finish.
-
-
Discover insights from Whitt Steineker on the proposed legislative changes aiming to revitalize Alabama's stagnant medical cannabis program. Dive deeper into the details on the Budding Trends blog: [https://bit.ly/3VLwNfU]
-
On this Medical Monday: Navigating the Future of Medical Cannabis: Insights from Americans for Safe Access on the Cannabis Rescheduling Proposal Focusing on the potential effects for medical cannabis patients, Americans For Safe Access recently held a high-level presentation and discussion on the rescheduling of cannabis. ➡️ Learn more on how rescheduling cannabis could affect #medicalcannabis across the nation: https://ow.ly/iOOw50RNz50
-
-
Cannabinoid Specialist; Harvard Medical School; Association of Cannabinoid Specialists. Seeking companies 2 make better meds.
It's Time Doctors Stand Up For Medical Cannabis Patients. Learn about how the Association of Cannabis Specialists is standing up for you and your patients! Support real medical care for real patients. https://bit.ly/476tC4a
-
-
Medical Research Consultant focusing on Advocacy, Education and Information for Cannabis Reform and Psychedelic Reform. Medical Professional (Retired)
Tilray Medical, a #division of Tilray Brands, Inc. ("Tilray") (#Nasdaq: TLRY; TSX: TLRY) and a #global #leader in #medical #cannabis, empowering the #therapeutic #alliance between #patients and #healthcare #practitioners to make #informed individualized #health #decisions, today announced a new Tilray-led #scientific #publication titled, Medical Cannabis for Patients Over Age 50: A Multi-Site, Prospective Study of Patterns of Use and Health Outcomes. The Medical Cannabis in Older Patients Study (“#MCOPS ”) is a #multisite, #prospective, #observational #study examining the #realworld #impact of #medical use on #patients over the #age of 50 and under the #guidance of a #healthcare #provider.
Tilray Medical announces scientific study on medical cannabis for patients over age 50. Learn more https://ow.ly/XuQh50SxKq5
-
-
It's an interesting time in Australia's medical cannabis landscape. Our complimentary short course, "History of Medical Cannabis," delves into the rich and complex journey of cannabis, from its ancient therapeutic use to its modern-day acceptance in healthcare. Gain a deeper understanding of cannabis in its historical context, the social attitudes that have shaped its status, and its impact in today's medical field. Enrol now at www.saged.com.au 🌿
-
-
#ICYMI The Kentucky Medical Cannabis Program has filed regulations establishing how qualified patients and caregivers can become medical cannabis cardholders in the commonwealth. These regulations are currently in the regulatory notice and comment period through May 31, 2024, and we encourage the public to provide feedback during this time. Learn more about the patient and caregiver cardholder regulations and review them here: https://lnkd.in/g2hEyddt
Regulations
kymedcan.ky.gov
-
Understanding the evolution of medical cannabis provides valuable context for healthcare practitioners to apply in their treatment and care of patients. We love receiving this feedback on our "History of Medical Cannabis" course! Complete this course to trial our learning platform. Visit www.saged.com.au.
-
-
At Argento Medical, we understand the difficult process of making end-of-life decisions. Together with cannabis prescribers, we acknowledge the complexities involved in these situations. Our priority is to help ease the burden on families during these challenging times, allowing them to focus on quality time together. Introducing medical cannabis into this equation could potentially provide comfort and additional support. #endoflifecare #support #cannabiseducation #medicalcannabis
-
-
Most global medical cannabis products are dispensed to patients 12-18 months after the flower is harvested. Consequently the cannabinoid and terpene concentrations will be reduced, and so too will be the patient's therapeutic experience. Our freshness mission is to dispense to the first patients within 28 days from end of cure, for each small batch. We are not there yet, but we are relentlessly working with our entire supply chain to reach our goal. What do you think? Does fresh cannabis make a difference to patients' therapeutic experience?
Global medical patients want to consume fresh cannabis, as it yields the best therapeutic outcomes. Sadly, fresh medical cannabis is difficult to find. Our freshness mission is to reach patients within 28 days from each crop's end of cure. We are not quite there yet, but rest assured, we will relentlessly work with our entire supply chain to achieve our goal. We'll keep you updated on our progress.
